A Phase II Clinical Trial Evaluating the Efficacy and Safety of SYS6026 Injection in Participants With HPV16 or 18-related High-grade Cervical Squamous Intraepithelial Lesions

NCT07702656 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

175

Enrollment

INDUSTRY

Sponsor class

Conditions

High-grade Cervical Intraepithelial Lesions

Interventions

BIOLOGICAL: SYS6026
BIOLOGICAL: Placebo

Sponsor

CSPC Megalith Biopharmaceutical Co.,Ltd.